EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome

Yiyuan Yin, Zhaojin Zeng, Senhao Wei, Ziyuan Shen, Zhukai Cong, Xi Zhu

International Immunopharmacology · 2024

DOI: 10.1016/j.intimp.2024.112670 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yiyuan Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Unit, Peking University Third Hospital, Beijing, China. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Adrenergic beta-Antagonists, Adrenergic alpha-2 Receptor Agonists, Sympathetic Nervous System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 162 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute Respiratory Distress Syndrome (ARDS) manifests as an acute inflammatory lung injury characterized by persistent hypoxemia, featuring a swift onset, high mortality, and predominantly supportive care as the current therapeutic approach, while effective treatments remain an area of active investigation. Adrenergic receptors (AR) play a pivotal role as stress hormone receptors, extensively participating in various inflammatory processes by initiating downstream signaling pathways. Advancements in molecular biology and pharmacology continually unveil the physiological significance of distinct AR subtypes. Interventions targeting these subtypes have the potential to induce specific alterations in cellular and organismal functions, presenting a promising avenue as a therapeutic target for managing ARDS. This article elucidates the pathogenesis of ARDS and the basic structure and function of AR. It also explores the relationship between AR and ARDS from the perspective of different AR subtypes, aiming to provide new insights for the improvement of ARDS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Distress SyndromeAdrenergic beta-AntagonistsAdrenergic alpha-2 Receptor AgonistsSympathetic Nervous SystemHumansAnimalsReceptors, AdrenergicSignal Transduction

Stichwörter der Autor:innen

Acute critical illnessAcute lung injuryAcute respiratory distress syndromeAdrenergic receptorsStress

Substanzen

Adrenergic beta-AntagonistsAdrenergic alpha-2 Receptor AgonistsReceptors, Adrenergic

Autor:innen und Institutionen

  • Department of Intensive Care Unit, Peking University Third Hospital, Beijing, China.
  • Department of Anaesthesiology, Peking University Third Hospital, Beijing, China.
  • Department of Anaesthesiology, Peking University Third Hospital, Beijing, China. Electronic address: bycongzhukai@bjmu.edu.cn.
  • Department of Intensive Care Unit, Peking University Third Hospital, Beijing, China. Electronic address: xizhuccm@bjmu.edu.cn.

Zitieren

APA

Yin, Y., Zeng, Z., Wei, S., Shen, Z., Cong, Z., & Zhu, X. (2024). Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112670

Vancouver

Yin Y, Zeng Z, Wei S, Shen Z, Cong Z, Zhu X. Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112670

BibTeX
@article{Yin2024,
  author = {Yin, Yiyuan and Zeng, Zhaojin and Wei, Senhao and Shen, Ziyuan and Cong, Zhukai and Zhu, Xi},
  title = {Using the sympathetic system, beta blockers and alpha-2 agonists, to address acute respiratory distress syndrome},
  journal = {International Immunopharmacology},
  year = {2024},
  doi = {10.1016/j.intimp.2024.112670}
}
Kostenlos starten →